Lipid Sciences Incorporated

(NASDAQ:LIPD)
  Jun 30, 2008 Mar 31, 2008 Dec 31, 2007 Sep 30, 2007
Cash Flow Statement
Cash At Beginning Of Period 6,459 6,459 16,691 16,691
Cash At End Of Period 2,374 4,235 6,459 9,167
Net Change In Cash And Cash Equivalents -4,085 -2,224 -10,232 -7,524
Effect Of Exchange Rate Changes
Net Income Or Loss -4,224 -2,239 -12,755 -8,542
Cash From Operating Activities
Depreciation Expenses 63 31 167 129
Amortization Expenses
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses 8 8
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables 4 4 -4 -96
Increase Or Decrease In Inventories
Increase Or Decrease In Prepaid Expenses 217 110 -181 54
Increase Or Decrease In Other Current Assets 217 110 -181 54
Increase Or Decrease In Payables 1
Increase Or Decrease In Other Current Liabilities -393 -405 852 556
Increase Or Decrease In Other Working Capital 17 117 -74 -232
Other Non Cash Items -1 1
Net Cash From Continuing Operations 287 213 1,843 655
Net Cash From Discontinued Operations -4,030 -2,169 -10,144 -7,467
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -55 -55 -93 -83
Acquisitions
Purchase Of Long Term Investments
Purchase Of Short Term Investments
Other Investing Changes Net
Cash From Discontinued Investing Activities
Net Cash From Investing Activities -55 -55 -93 -83
Cash From Financing Activities
Issuance Of Debt 5 26
Issuance Of Capital Stock
Repayment Of Debt
Repurchase Of Capital Stock
Payment Of Cash Dividends
Net Other Financing Charges
Cash From Discontinued Financing Activities
Net Cash From Financing Activities 5 26